Advertisement

DNA Aneuploid Cells Showing Discrepancy of Expression Between c-myc Oncogene Products and GFAP in Malignant Glioma

  • Nobuyuki Sakai
  • Keiji Kawamoto
  • Hiroshi Matsumura

Abstract

There are various reports on brain tumors in the rapidly developing research on oncogenes which have been noted to be associated with human malignant tumors. We have made an analytical study of the cell growth of brain tumors using flow cytometry (FCM), and further evaluated our results by applying simultaneous double staining using anti c-myc or GFAP monoclonal antibodies (MoAb). In the present study we described an interesting finding in the relationship between c-myc oncogene products and DNA content in malignant glioma cells obtained at surgery.

Keywords

Glioma Cell Double Staining Glioma Cell Line Malignant Glioma Cell Aneuploid Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Sakai N, Kawamoto K, Numa Y, Shoda Y, Matsumura H (1989) Comparison of DNA aneuploidy and histological malignancy in brain tumors. Flow Cytometry 9: 37–42Google Scholar
  2. 2.
    Kawamoto K, Inagaki T, Sakai N, Ohuchi M, Yasuda T, Suwa J, Seto Y, Matsu-mura H (1988) Correlation of the cell cycle of glioma with GFAP staining on flow cytometry, using PI-FITC-labelled GFAP double staining technique. Flow Cytometry 8: 48–53Google Scholar
  3. 3.
    Sakai N, Kawamoto K, Matsumura H (1989) Flowcytometric analysis on the expression of c-myc products in cultured brain tumors. Neuroimmunol Res 2: 183–187Google Scholar
  4. 4.
    Kawamoto K, Sakai N, Imahori T, Matsumura H (1990) Proposal for new classification of DNA-ploidy by flow cytometry. Flow Cytometry 10: 124–131Google Scholar
  5. 5.
    Garson JA, Mclntyre PG, Kemshed JT (1985) N-myc amplification in malignant astrocytoma. Lancet 11: 718–719CrossRefGoogle Scholar
  6. 6.
    Bigner SH, Wong AJ, Mark J, Muhlbaier LH, Kinzler KW, Vogelstein B, Bigner DD (1987) Relationship between gene amplification and chromosomal deviations in malignant human gliomas. Cancer Genet Cytogenet 29: 165–170PubMedCrossRefGoogle Scholar
  7. 7.
    Trent J, Meltzr P, Rosenblum M, Harsh G, Kinzler K, Mashai R, Feinberg A, Vogelstein B (1986) Evidence for rearrangement, amplification, and expression of c-myc in a human glioblastoma. Proc Natl Acad Sci USA 83: 470–473PubMedCrossRefGoogle Scholar
  8. 8.
    Fujimoto M, Weaker FJ, Herbert DC, Sharp ZD, Sheridan PJ, Story JL (1988) Expression of three viral oncogenes (v-sis, v-myc, v-fos) in primary human brain tumors of neuroectodermal origin. Neurology 38: 289–293PubMedGoogle Scholar
  9. 9.
    Zimmerman KA, Yancopoulus GD, Collum RG, Smith RK, Kohl NE, Denis KA, Nau MM, Witte ON, Toran-Allerand D, Gee CE, Minna JD, Alt FW (1986) Differential expression of c-myc family genes during murine development. Nature 319: 780–783PubMedCrossRefGoogle Scholar
  10. 10.
    Goyette M, Petropoonlos CJ, Shank PR, Faust N (1983) Expression of a cellular oncogene during liver regeneration. Science 219: 510–517PubMedCrossRefGoogle Scholar
  11. 11.
    Watson JV, Sikora K, Evan GI (1985) A simultaneous flow cytometric assay for c-myc oncoprotein and DNA in nuclei from paraffin embedded material. J Immunol Methods 83: 179–192PubMedCrossRefGoogle Scholar
  12. 12.
    Suzuki C, Nagashima C, Noritake S, Takahama M (1986) Oncobiology of the human brain tumor cells with special reference to the two-color immunofluorescence analysis of Vimentin/GFAP and BUdR labelling with use of flow cytometry. Brain Tumor Pathol 4: 69–76Google Scholar

Copyright information

© Springer-Verlag Tokyo 1991

Authors and Affiliations

  • Nobuyuki Sakai
  • Keiji Kawamoto
  • Hiroshi Matsumura
    • 1
  1. 1.Department of NeurosurgeryKansai Medical UniversityMoriguchi, 570Japan

Personalised recommendations